caused, revenue from sales of export increased about 21% and revenue from sales of domestic decreased about 12%. Analysis of Profit of company and its subsidiaries In 2017, the company and its subsidiaries

was decreased by Baht 15.89 million which details are as following; (1) Revenue from sales In the first quarter of 2019, the Company and its subsidiaries had total revenue from sales at the amount of

to explain overall operation for the quarter 2nd of year 2020 with following details. Unit: Million THB Description 3-month period ending 30th Jun 2020 3-month period ending 30th Jun 2019 Differentiate

, Thailand, made the following resolutions pertaining to the important agenda as follows: 1) Liquidation of Advanced Biochemical Europe Resolved to approve the liquidation of Advanced Biochemical Europe

, with 0.18 million baht decrease with no significantly transaction changes. 2. Cost of sale , Profit margin For Quarter 1 of the year 2020, the company had cost of sale of 98.36 million bath compare to

1,554.5 1,174.8 1,557.6 379.7 32.3 (3.1) (0.2) Profit for the period 123.0 96.8 121.6 26.2 27.1 1.4 1.2 Overall in the Q2–2023, the Thai economy slightly improved from the previous quarter due to the

subsidiaries financial statement for the fiscal year 2014, ended as of December 31, 2014 (Revised Version) which details are as following; Result 2014 (Revised Version) 2013 Increase (Decrease) Million Baht

of the Company and its subsidiaries for the first quarter of 2018 which reviewed by the auditor of the Company, details are following. 1. The Operating Results Analysis For the first quarter of 2018

to mid-single digit decline. EBITDA (pre- TFRS16) stood at Bt76,619mn, decreased –2. 7% YoY with focusing on cost control and in- line with low single digit decline EBITDA guidance. Net profit ( pre

Q4 which created a decline in mobile service revenue in this quarter. Following the EBITDA movement, AIS reported a net profit of Bt6,757mn, improved 7.1% YoY from better operating performance, lower